Use of the beta-lactamase inhibitor clavulanic acid in the isolation of auxotrophic mutants of Bacillus licheniformis
Links to Files
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC215723/Permanent Link
http://hdl.handle.net/11603/13275Metadata
Show full item recordDate
1984-08Type of Work
2 pagesText
journal articles
Citation of Original Publication
P I Fields, H J Schreier, A L Saha, and R W Bernlohr, Use of the beta-lactamase inhibitor clavulanic acid in the isolation of auxotrophic mutants of Bacillus licheniformis., J Bacteriol. 1984 Aug; 159(2): 803–804, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC215723/Rights
This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.Abstract
The isolation of auxotrophic mutants of Bacillus licheniformis, a microbe containing constitutive ,β-lactamase
activity, was found to be facilitated by the addition of clavulanic acid and cefotaxime during enrichment.